Juvenile papillomatosis in the larynx papillomatosis is a disease more frequent between 3 and 5 laryngeal papillomatosis treatment, characterised by multiple relapses and exuberant growth at the level of the laryngeal mucosa.
The annual costs of the laryngeal papillomatosis treatment of this disease are over million USD. Objectives: bringing new informations about the etiology, the diagnosis and the treatment of the disease for the papillomatosis in the larynx that deal with this pathology, especially paediatrics and otolaryngologists.
The evolution of the patients with laryngeal papillomatosis depends on the early laryngeal papillomatosis treatment and the corresponding treatment. Material and method: using data from laryngeal papilloma lesions literature of specialty and the clinical experience in laryngeal papillomatosis treatment ENT Clinic in Timisoara we present actualities in the epidemiology, the diagnosis and the treatment in the juvenile laryngeal papillomatosis. Conclusions: juvenile laryngeal papillomatosis is caused by the HPV types 6 and The treatment follows two objectives: relapses and the reestablishment of the respiratory and phonatory function.